|
|
|
Insider
Information: |
Sabella Lauren M |
Relationship: |
|
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
386,061 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$1,765,773 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
386,061 |
|
|
Total
Value |
$1,765,773 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Acorda Therapeutics Inc |
ACOR |
Chief Operating Officer |
2022-09-03 |
10,710 |
|
0 |
Premium* |
|
MannKind Corp |
MNKD |
|
2024-05-15 |
375,351 |
2023-05-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
42 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
MNKD |
MannKind Corp |
EVP Chief Operating Officer |
|
2023-05-22 |
4 |
A |
$0.00 |
$0 |
D/D |
210,000 |
224,184 |
0 |
- |
|
MNKD |
MannKind Corp |
EVP Chief Operating Officer |
|
2023-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
23,250 |
247,434 |
0 |
- |
|
MNKD |
MannKind Corp |
EVP Chief Operating Officer |
|
2023-12-31 |
4 |
A |
$3.09 |
$2,197 |
D/D |
711 |
248,145 |
0 |
- |
|
MNKD |
MannKind Corp |
EVP Chief Operating Officer |
|
2024-02-04 |
4 |
A |
$3.27 |
$49,998 |
D/D |
15,290 |
263,435 |
0 |
- |
|
MNKD |
MannKind Corp |
EVP Chief Operating Officer |
|
2024-03-27 |
4 |
D |
$4.63 |
$79,099 |
D/D |
(17,084) |
246,351 |
0 |
- |
|
MNKD |
MannKind Corp |
EVP Chief Operating Officer |
|
2024-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
129,000 |
375,351 |
0 |
- |
|
ACOR |
Acorda Therapeutics Inc |
Exec. VP-Commercial Dvlpmnt |
|
2010-12-01 |
4 |
AS |
$26.53 |
$104,342 |
D/D |
(3,933) |
21,067 |
0 |
- |
|
ACOR |
Acorda Therapeutics Inc |
Exec. VP-Commercial Dvlpmnt |
|
2011-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
10,313 |
31,380 |
0 |
- |
|
ACOR |
Acorda Therapeutics Inc |
Exec. VP-Commercial Dvlpmnt |
|
2011-12-01 |
4 |
AS |
$22.91 |
$99,979 |
D/D |
(4,364) |
27,016 |
0 |
- |
|
ACOR |
Acorda Therapeutics Inc |
Exec. VP-Commercial Dvlpmnt |
|
2012-12-04 |
4 |
AS |
$24.58 |
$107,259 |
D/D |
(4,364) |
31,652 |
0 |
- |
|
ACOR |
Acorda Therapeutics Inc |
Exec. VP-Commercial Dvlpmnt |
|
2013-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
7,100 |
38,752 |
0 |
- |
|
ACOR |
Acorda Therapeutics Inc |
Exec. VP-Commercial Dvlpmnt |
|
2013-11-22 |
4 |
AS |
$33.72 |
$369,206 |
D/D |
(10,949) |
27,803 |
0 |
- |
|
ACOR |
Acorda Therapeutics Inc |
Exec. VP-Commercial Dvlpmnt |
|
2013-12-02 |
4 |
AS |
$33.52 |
$221,319 |
D/D |
(6,603) |
21,200 |
0 |
- |
|
ACOR |
Acorda Therapeutics Inc |
Exec. VP-Commercial Dvlpmnt |
|
2013-12-05 |
4 |
AS |
$31.81 |
$279,830 |
D/D |
(8,797) |
12,403 |
0 |
- |
|
ACOR |
Acorda Therapeutics Inc |
Exec. VP-Commercial Dvlpmnt |
|
2014-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
18,403 |
0 |
- |
|
ACOR |
Acorda Therapeutics Inc |
Exec. VP-Commercial Dvlpmnt |
|
2014-12-01 |
4 |
AS |
$35.58 |
$115,344 |
D/D |
(3,242) |
15,161 |
0 |
- |
|
ACOR |
Acorda Therapeutics Inc |
Exec. VP-Commercial DvlpmntOff |
|
2010-01-28 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
25,000 |
|
- |
|
42 Records found
|
|
Page 2 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|